There’s no better time than now to be in the Canadian marijuana industry.


With legalization slated for summer 2018, interest in the sector is hotter than ever– at a Canadian level but also at a global scale–as recreational legalization will no doubt impact the framework for other countries looking to make similar steps moving forward.

On that note, at the CanTech Investment Conference in Toronto on January 31, the Investing News Network (INN) had the opportunity to speak with Chris Wagner, CEO of Emerald Health Therapeutics (TSXV:EMH) to discuss how Canada’s framework for legalization will be impactful at a global scale. Wagner said that Canadian companies, including ones like Emerald Health, are developing new cannabis products that are useful not just for Canadians, but for people all around the world.

“We’re creating new formulations, new ways of delivering cannabis, new products … and exporting those around the world,” Wagner said.

Similarly, when legalization in Canada comes to fruition in a few months, demand will, unsurprisingly, increase. For Emerald Health, Wagner said the company has already been supplying medical cannabis to its patients for over four years, so he said the company knows “exactly what people want.”

“We’re preparing for the adult-use market by converting large-scale greenhouses … into cannabis-growing facilities,” he said. “This one million square foot greenhouse facility will be able to produce 750,000 kilograms of cannabis.”

In addition to officially preparing for legalization to come into full swing, Wagner also spoke about Emerald Health’s joint venture with DMG Blockchain, called CannaChain, and the impact blockchain will have on the cannabis industry.

To watch the interview, scroll to the top of the article for more of what Wagner had to say.

Don’t forget to follow us @INN_Technology for real-time news updates! 

Securities Disclosure: I, Jocelyn Aspa, hold no direct investment interest in any company mentioned in this article. 

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less